Dextromethorphan Polistirex

Migraine, Catarrh, Sneezing + 20 more

Treatment

20 Active Studies for Dextromethorphan Polistirex

What is Dextromethorphan Polistirex

Dextromethorphan

The Generic name of this drug

Treatment Summary

Dextromethorphan is a medication used to reduce coughing. It is similar to codeine in its chemical structure, but it does not interact with opioid receptors like other opioids. It was approved by the FDA before December 1957 and is also sometimes misused as a drug of abuse.

Goyescas 7 Syrups Original Cough and Cold

is the brand name

image of different drug pills on a surface

Dextromethorphan Polistirex Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Goyescas 7 Syrups Original Cough and Cold

Dextromethorphan

1958

356

Effectiveness

How Dextromethorphan Polistirex Affects Patients

Dextromethorphan is a type of drug used to treat coughs and certain emotional conditions. It has a limited safe range (too much can be harmful) and it works for a moderate amount of time. People should be made aware of the risks of taking too much of this drug.

How Dextromethorphan Polistirex works in the body

We don't know exactly how dextromethorphan works, but it appears to interact with certain nerve cell receptors. Specifically, it acts as an agonist of NMDA and sigma-1 receptors, and an antagonist of alpha-3/beta-4 nicotinic receptors.

When to interrupt dosage

The suggested dosage of Dextromethorphan Polistirex is contingent upon the diagnosed state, such as Coughing, Fever and Antisepsis. The measure of dosage changes in accordance with the system of administration specified in the table below.

Condition

Dosage

Administration

Itching of the throat

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Acute Bronchitis

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Pseudobulbar Affect (PBA)

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Eye

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Antisepsis

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Bronchitis

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Coughing

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Rhinorrhea

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Coughing

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Migraine

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Catarrh

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Influenza

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Nasal Congestion

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Influenza

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Sneezing

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Fever

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Airway secretion clearance therapy

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Coughing

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Coughing

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

upper respiratory symptoms

, 7.5 mg/mL, 5.0 mg/mL, 1.5 mg/mL, 2.0 mg/mL, 3.0 mg/mL, 15.0 mg, 10.0 mg/mL, 15.0 mg/mL, 10.0 mg, 1.0 mg/mL, 20.0 mg, 30.0 mg, 5.0 mg, 30.0 mg/mL, 20.0 mg/mL, 100.0 mg/mL, 2.75 mg/mL, 28.0 mg/mL, 28.0 mg, 0.15 mg/mg, 0.0015 mg/mg, 0.075 mg/mg, 12.5 mg/mL, 1.333 mg/mL, 4.0 mg/mL, 2.5 mg/mL, 60.0 mg, 1.8 mg/mL, 60.0 mg/mL, 10.5 mg, 160.0 mg/mL, 8.0 mg, 0.04 mg/mg, 10.0 mg/mg, 0.01 mg, 7.5 mg, 3.75 mg, 2.5 mg, 17.5 mg, 0.02 mg/mg, 0.03 mg/mg, 9.0 mg, 6.0 mg/mL, 14.0 mg, 57.5 mg, 25.0 mg, 5.8 mg/mL, 55.0 mg, 20000.0 mg, 18.0 mg/mL, 18.0 mg, 25.0 mg/mL, 0.75 mg/mL, 1.3 mg/mL, 6.5 mg/mL, 0.025 mg/mg, 50.0 mg, 0.667 mg/mL, 0.00515 mg/mg, 0.00525 mg/mg, 1.667 mg/mL, 0.2 mg/mL, 2.0 mL/mL, 0.01 mg/mg, 0.002 mg/mg, 0.003 mg/mg, 1.0 mL/mL, 7.5 mg/units, 2.85 mg/mL

Oral, , Liquid - Oral, Liquid, Solution, Solution - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Syrup, Powder, for solution, Tablet, coated, Syrup - Oral, Suspension - Oral, Suspension, Tablet, coated - Oral, Powder, for solution - Oral, Tablet, film coated, Tablet, film coated - Oral, Kit, Powder, Tablet, effervescent, Granule, effervescent - Oral, Tablet, effervescent - Oral, Powder - Oral, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Granule, for solution, Granule, for solution - Oral, Capsule - Oral, Capsule, Tablet, Granule, effervescent, Tablet - Oral, Lozenge - Oral, Elixir - Oral, Elixir, Suspension, extended release, Solution / drops - Oral, Capsule, coated - Oral, Suspension, extended release - Oral, Lozenge, Suspension / drops - Oral, Suspension / drops, Solution / drops, Capsule, coated, Tablet, sugar coated - Oral, Solution / drops - Nasal, Nasal, Tablet, extended release - Oral, Tablet, extended release, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Spray - Oral, Spray, Granule - Oral, Granule, Tablet, sugar coated, Patch - Topical, Topical, Strip, Strip - Oral, Tablet, chewable - Oral, Tablet, chewable, Patch, Kit; Tablet, Kit; Tablet - Oral, Kit; Powder, for solution - Oral, Capsule; Kit, Capsule; Kit - Oral, Kit; Powder, Kit; Powder - Oral, Kit - Oral, Liquid - Topical, Kit; Powder, for solution, Nasal; Oral, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical

Warnings

Dextromethorphan Polistirex has one contraindication, thus it should not be utilized together with the conditions in the following table.

Dextromethorphan Polistirex Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Dextromethorphan may interact with Pulse Frequency

There are 20 known major drug interactions with Dextromethorphan Polistirex.

Common Dextromethorphan Polistirex Drug Interactions

Drug Name

Risk Level

Description

Amitriptyline

Major

The metabolism of Amitriptyline can be decreased when combined with Dextromethorphan.

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Dextromethorphan.

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Dextromethorphan.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Dextromethorphan.

Azelastine

Major

Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Dextromethorphan Polistirex Toxicity & Overdose Risk

Signs of overdosing on dextromethorphan include nausea, vomiting, confusion, shallow breathing, seizures, rapid heartbeat, over-excitability, abnormal behavior, lack of coordination, vision problems, changes in muscle reflexes, and serotonin syndrome. Treatment of an overdose should focus on providing symptom relief.

image of a doctor in a lab doing drug, clinical research

Dextromethorphan Polistirex Novel Uses: Which Conditions Have a Clinical Trial Featuring Dextromethorphan Polistirex?

134 active clinical trials are examining the potential of Dextromethorphan Polistirex for the management of Influenza, Pseudobulbar Affect (PBA) and Coughing symptoms.

Condition

Clinical Trials

Trial Phases

Migraine

13 Actively Recruiting

Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4

Catarrh

0 Actively Recruiting

Airway secretion clearance therapy

0 Actively Recruiting

upper respiratory symptoms

0 Actively Recruiting

Rhinorrhea

0 Actively Recruiting

Pseudobulbar Affect (PBA)

0 Actively Recruiting

Antisepsis

0 Actively Recruiting

Influenza

29 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3

Eye

0 Actively Recruiting

Acute Bronchitis

7 Actively Recruiting

Phase 4, Not Applicable, Phase 3, Early Phase 1

Influenza

0 Actively Recruiting

Itching of the throat

0 Actively Recruiting

Sneezing

0 Actively Recruiting

Coughing

0 Actively Recruiting

Coughing

0 Actively Recruiting

Nose

0 Actively Recruiting

Fever

2 Actively Recruiting

Not Applicable, Phase 4

Coughing

0 Actively Recruiting

Bronchitis

0 Actively Recruiting

Coughing

0 Actively Recruiting

Dextromethorphan Polistirex Reviews: What are patients saying about Dextromethorphan Polistirex?

5

Patient Review

12/31/2014

Dextromethorphan Polistirex for Cough

I gave this to my son who was suffering from a really bad cough. It helped him immensely and allowed him to finally get some restful sleep. We only used it for a few nights within a ten day period when his flu was at its worst.

4

Patient Review

4/22/2021

Dextromethorphan Polistirex for Cough

This medicine effectively stopped my cough, but unfortunately came with some intense side effects like nausea and dizziness. I took the correct dose for an adult, so I'm not sure if it's worth it for others.

2.3

Patient Review

12/21/2017

Dextromethorphan Polistirex for Cough

I tried this medication and it didn't do anything to help my cough, neither short-term or long-term. If anything, it made my coughing fits worse and gave me killer headaches.

2.3

Patient Review

1/2/2019

Dextromethorphan Polistirex for Cough

I've been using this for several days to try and mitigate a cough I contracted from a cold. So far, no improvement; if anything, it might even be worse now. Not only am I coughing just as much, but also blood due to the intensity of my fits.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about dextromethorphan polistirex

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is dextromethorphan polistirex a narcotic?

"Dextromethorphan is similar to codeine but does not have the same effects. Dextromethorphan suppresses cough by reducing the excitability of the cough center in the brain."

Answered by AI

What does dextromethorphan polistirex do?

"This medication is used to temporarily relieve coughs that are caused by certain infections of the air passages, such as sinusitis or the common cold."

Answered by AI

What is Polistirex?

"Hydrocodone polistirex is a narcotic cough suppressant that works by suppressing the cough reflex in the brain. Chlorpheniramine polistirex is an antihistamine that is used to treat the symptoms of allergies. When used for a long period of time, hydrocodone polistirex can be addictive."

Answered by AI

Is dextromethorphan polistirex the same as dextromethorphan?

"The time release feature allows the drug to work for a longer period of time. The active ingredient per teaspoon (5 mL) is dextromethorphan polistirex, equivalent to dextromethorphan HBr 30 mg."

Answered by AI

Clinical Trials for Dextromethorphan Polistirex

Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Have you considered Dextromethorphan Polistirex clinical trials?

We made a collection of clinical trials featuring Dextromethorphan Polistirex, we think they might fit your search criteria.
Go to Trials
Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.

Phase 2
Waitlist Available

National Institutes of Health Clinical Center (+1 Sites)

Luca T Giurgea, M.D.

Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN

This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?

Phase 2
Recruiting

Vanderbilt University Medical Center

Natahsa Halasa, MD, MPH

Image of Altasciences Inc - Kansas City in Overland Park, United States.

VNT-101 for Safety and Tolerability Study

18 - 59
All Sexes
Overland Park, KS

A randomized, double-blind, placebo-controlled Phase 1 study conducted at a single center with approximately 78 healthy adults aged 18-59 years. Part 1 Single Ascending Dose (SAD) will enroll 48 participants into six cohorts (S1-S6) to receive single oral doses of VNT-101 (100-1500 mg) or placebo under fasting or fed (S5 only) conditions. Part 2 Multiple Ascending Dose (MAD) will enroll 30 participants into three cohorts (M1-M3) to receive multiple oral doses of VNT-101 (250-750 mg BID Days 1-5, QD Day 6) or placebo under fasting conditions. Dose escalation in both parts will proceed after Protocol Safety Review Team (PSRT) review. The primary objective for Part 1 is to evaluate the safety and tolerability of single ascending oral (SAD) doses of VNT-101 in healthy adult participants under either fasting or fed conditions. The primary objective for part 2 is to evaluate the safety and tolerability of multiple ascending oral (MAD) doses of VNT-101 in healthy adult participants.

Phase 1
Recruiting

Altasciences Inc - Kansas City

Have you considered Dextromethorphan Polistirex clinical trials?

We made a collection of clinical trials featuring Dextromethorphan Polistirex, we think they might fit your search criteria.
Go to Trials
Image of Miami Valley Hospital in Dayton, United States.

Intranasal Nerve Block for Headache

18+
All Sexes
Dayton, OH

In patients with bleeding from a brain aneurysm, severe headache is the most common complaint. However, the pain is difficult to treat. The use of standard pain medications is common, but pain control remains poor. Additionally, pain medicines have multiple side effects including sedation, interference with breathing, intestinal cramping, low blood pressure, and the risk of addiction. In the present study, the investigators will examine the use of a medication to block the sphenopalatine ganglion which is a bundle of nerves that includes nerves that cause head pain. This block is performed by spraying numbing medication into the back of the nasal cavity on both sides. This particular pain medication does not have the side effects discussed above. The purpose of the study is to see if this treatment will decrease pain without causing unwanted side effects. All patients in the study will receive standard pain medicine as needed for headache. Information will be collected from the patient's medical chart on the amount of pain medication used and the amount of pain the patient describes having. The average pain will be calculated for the first 24 hours the patient is in the hospital. At that point, the patient will receive pain medication sprayed into the back of the nasal cavity on both sides. Patients will also receive this treatment 3 days later. Following these treatments, information will be obtained on the average amount of pain, and how much other pain medication is used. The investigators will look at the amount of pain and the amount of other pain medicine used over the first 24 hours before the nasal pain medicine treatment and compare it to the time after the treatments to see if the amount of pain decreases and if the amount of other pain medicine needed decreases as well. Six months after discharge, the patient will be contacted by phone to find out more information about how much head pain they had after discharge from the hospital.

Phase 4
Recruiting

Miami Valley Hospital

Image of University of Maryland, School of Medicine, Center for Vaccine Development and Global Health in Baltimore, United States.

pH1N1 Virus for Flu

18 - 55
All Sexes
Baltimore, MD

This protocol describes a clinical trial to develop and validate a Controlled Human Infection Model (CHIM) for influenza A/Arkansas/08/2020 (pH1N1). The study is designed to determine the optimal infectious dose of the pH1N1 challenge strain for use in future clinical trials evaluating influenza countermeasures. The study will enroll and challenge adult volunteers with the pH1N1 influenza virus challenge or sham inoculations. Given the adaptive design of this trial, the potential number of participants can vary. Depending on the pathway recommended by the PSRT and followed in the Trial Schema, the study population can range from around 30 to 120. However, it is anticipated that the final sample size will be around 60 participants receiving pH1N1 challenge product plus approximately 4 persons receiving a sham inoculation. Participants will be pre-screened for health and for serological HAI antibody titers of \</1:40 against the challenge strain. Eligible participants will be enrolled sequentially into challenge cohorts and will be randomly assigned to receive a single dose of either sham inoculation or the interventional study product at a dose between 10\^6 to 10\^7 TCID50 (or 10\^5 TCID50 if needed). Dose titration will be conducted under an adaptive escalation schedule whereby dosing will start at 10\^6 TCID50 and escalate to the next dose if a pre-determined symptomatic influenza attack rate and clinical symptom score thresholds are not met and if the dose is determined to be safe with no pre-defined halting criteria being met. The primary objectives of this study are to determine the optimal infectious dose of a pH1N1 viral challenge to cause laboratory-confirmed clinical influenza and to assess the safety profile of pH1N1 viral challenge.

Phase 1
Recruiting

University of Maryland, School of Medicine, Center for Vaccine Development and Global Health (+1 Sites)

Have you considered Dextromethorphan Polistirex clinical trials?

We made a collection of clinical trials featuring Dextromethorphan Polistirex, we think they might fit your search criteria.
Go to Trials